-
1
-
-
84872862768
-
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
-
Anglesio MS, Kommoss S, Tolcher MC, Clarke B, Galletta L, Porter H, et al. Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas. J Pathol. 2013;229:111-20. doi: 10.1002/path.4088 .
-
(2013)
J Pathol
, vol.229
, pp. 111-120
-
-
Anglesio, M.S.1
Kommoss, S.2
Tolcher, M.C.3
Clarke, B.4
Galletta, L.5
Porter, H.6
-
2
-
-
84866905581
-
Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and ras pathway aberrations
-
Hunter SM, Gorringe KL, Christie M, Rowley SM, Bowtell DD, Campbell IG. Pre-invasive ovarian mucinous tumors are characterized by CDKN2A and ras pathway aberrations. Clin Cancer Res. 2012;18:5267-77. doi: 10.1158/1078-0432.CCR-12-1103 .
-
(2012)
Clin Cancer Res
, vol.18
, pp. 5267-5277
-
-
Hunter, S.M.1
Gorringe, K.L.2
Christie, M.3
Rowley, S.M.4
Bowtell, D.D.5
Campbell, I.G.6
-
3
-
-
70349334416
-
Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis
-
Gorringe KL, Ramakrishna M, Williams LH, Sridhar A, Boyle SE, Bearfoot JL, et al. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis. Gene Chromosome Canc. 2009;48:931-42. doi: 10.1002/gcc.20694 .
-
(2009)
Gene Chromosome Canc
, vol.48
, pp. 931-942
-
-
Gorringe, K.L.1
Ramakrishna, M.2
Williams, L.H.3
Sridhar, A.4
Boyle, S.E.5
Bearfoot, J.L.6
-
4
-
-
36749085834
-
Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer
-
Merritt MA, Green AC, Nagle CM, Webb PM. Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer. 2008;122:170-6. doi: 10.1002/ijc.23017 .
-
(2008)
Int J Cancer
, vol.122
, pp. 170-176
-
-
Merritt, M.A.1
Green, A.C.2
Nagle, C.M.3
Webb, P.M.4
-
5
-
-
0030041917
-
Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q
-
Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD, Campbell IG. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res. 1996;56:719-21.
-
(1996)
Cancer Res
, vol.56
, pp. 719-721
-
-
Bryan, E.J.1
Watson, R.H.2
Davis, M.3
Hitchcock, A.4
Foulkes, W.D.5
Campbell, I.G.6
-
6
-
-
0037373080
-
The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases
-
Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27:281-92.
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 281-292
-
-
Lee, K.R.1
Young, R.H.2
-
7
-
-
84866932831
-
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles
-
Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, et al. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet. 2012;8, e1002894. doi: 10.1371/journal.pgen.1002894 .
-
(2012)
PLoS Genet
, vol.8
-
-
Thompson, E.R.1
Doyle, M.A.2
Ryland, G.L.3
Rowley, S.M.4
Choong, D.Y.5
Tothill, R.W.6
-
8
-
-
84872931911
-
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary
-
Ryland GL, Hunter SM, Doyle MA, Rowley SM, Christie M, Allan PE, et al. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol. 2013;229:469-76. doi: 10.1002/path.4134 .
-
(2013)
J Pathol
, vol.229
, pp. 469-476
-
-
Ryland, G.L.1
Hunter, S.M.2
Doyle, M.A.3
Rowley, S.M.4
Christie, M.5
Allan, P.E.6
-
9
-
-
84864598664
-
MuSiC: identifying mutational significance in cancer genomes
-
Dees ND, Zhang Q, Kandoth C, Wendl MC, Schierding W, Koboldt DC, et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 2012;22:1589-98. doi: 10.1101/gr.134635.111 .
-
(2012)
Genome Res
, vol.22
, pp. 1589-1598
-
-
Dees, N.D.1
Zhang, Q.2
Kandoth, C.3
Wendl, M.C.4
Schierding, W.5
Koboldt, D.C.6
-
10
-
-
84938624253
-
-
IntOGen Mutations 2014.12. http://www.intogen.org
-
(2014)
-
-
-
11
-
-
84870599966
-
Functional impact bias reveals cancer drivers
-
Gonzalez-Perez A, Lopez-Bigas N. Functional impact bias reveals cancer drivers. Nucleic Acids Res. 2012;40, e169. doi: 10.1093/nar/gks743 .
-
(2012)
Nucleic Acids Res
, vol.40
-
-
Gonzalez-Perez, A.1
Lopez-Bigas, N.2
-
12
-
-
84887032986
-
IntOGen-mutations identifies cancer drivers across tumor types
-
Gonzalez-Perez A, Perez-Llamas C, Deu-Pons J, Tamborero D, Schroeder MP, Jene-Sanz A, et al. IntOGen-mutations identifies cancer drivers across tumor types. Nat Methods. 2013;10:1081-2. doi: 10.1038/nmeth.2642 .
-
(2013)
Nat Methods
, vol.10
, pp. 1081-1082
-
-
Gonzalez-Perez, A.1
Perez-Llamas, C.2
Deu-Pons, J.3
Tamborero, D.4
Schroeder, M.P.5
Jene-Sanz, A.6
-
13
-
-
33847147313
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
-
Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118-45. doi: 10.1200/JCO.2006.09.2775 .
-
(2007)
J Clin Oncol
, vol.25
, pp. 118-145
-
-
Wolff, A.C.1
Hammond, M.E.2
Schwartz, J.N.3
Hagerty, K.L.4
Allred, D.C.5
Cote, R.J.6
-
14
-
-
84892833777
-
Discovery and saturation analysis of cancer genes across 21 tumour types
-
Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505:495-501. doi: 10.1038/nature12912 .
-
(2014)
Nature
, vol.505
, pp. 495-501
-
-
Lawrence, M.S.1
Stojanov, P.2
Mermel, C.H.3
Robinson, J.T.4
Garraway, L.A.5
Golub, T.R.6
-
15
-
-
84880507665
-
Mutational heterogeneity in cancer and the search for new cancer-associated genes
-
Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214-8. doi: 10.1038/nature12213 .
-
(2013)
Nature
, vol.499
, pp. 214-218
-
-
Lawrence, M.S.1
Stojanov, P.2
Polak, P.3
Kryukov, G.V.4
Cibulskis, K.5
Sivachenko, A.6
-
16
-
-
0028074299
-
DNA methylation and cancer
-
Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet. 1994;3:1487-95.
-
(1994)
Hum Mol Genet
, vol.3
, pp. 1487-1495
-
-
Laird, P.W.1
Jaenisch, R.2
-
17
-
-
0028790862
-
A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line
-
Huang Y, Saez R, Chao L, Santos E, Aaronson SA, Chan AM. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. Oncogene. 1995;11:1255-60.
-
(1995)
Oncogene
, vol.11
, pp. 1255-1260
-
-
Huang, Y.1
Saez, R.2
Chao, L.3
Santos, E.4
Aaronson, S.A.5
Chan, A.M.6
-
18
-
-
0028016358
-
Activation of the K-ras gene by insertion mutations in chemically induced rat renal mesenchymal tumors
-
Higinbotham KG, Rice JM, Buzard GS, Perantoni AO. Activation of the K-ras gene by insertion mutations in chemically induced rat renal mesenchymal tumors. Oncogene. 1994;9:2455-9.
-
(1994)
Oncogene
, vol.9
, pp. 2455-2459
-
-
Higinbotham, K.G.1
Rice, J.M.2
Buzard, G.S.3
Perantoni, A.O.4
-
19
-
-
0034626694
-
Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling
-
Klockow B, Ahmadian MR, Block C, Wittinghofer A. Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling. Oncogene. 2000;19:5367-76. doi: 10.1038/sj.onc.1203909 .
-
(2000)
Oncogene
, vol.19
, pp. 5367-5376
-
-
Klockow, B.1
Ahmadian, M.R.2
Block, C.3
Wittinghofer, A.4
-
20
-
-
77951640946
-
A method and server for predicting damaging missense mutations
-
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248-9. doi: 10.1038/nmeth0410-248 .
-
(2010)
Nat Methods
, vol.7
, pp. 248-249
-
-
Adzhubei, I.A.1
Schmidt, S.2
Peshkin, L.3
Ramensky, V.E.4
Gerasimova, A.5
Bork, P.6
-
21
-
-
0035026704
-
Predicting deleterious amino acid substitutions
-
Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11:863-74. doi: 10.1101/gr.176601 .
-
(2001)
Genome Res
, vol.11
, pp. 863-874
-
-
Ng, P.C.1
Henikoff, S.2
-
22
-
-
80053189298
-
Predicting the functional impact of protein mutations: application to cancer genomics
-
Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011. doi: 10.1093/nar/gkr407 .
-
(2011)
Nucleic Acids Res
-
-
Reva, B.1
Antipin, Y.2
Sander, C.3
-
23
-
-
66249120367
-
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
-
Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37, e67. doi: 10.1093/nar/gkp215 .
-
(2009)
Nucleic Acids Res
, vol.37
-
-
Desmet, F.O.1
Hamroun, D.2
Lalande, M.3
Collod-Beroud, G.4
Claustres, M.5
Beroud, C.6
-
24
-
-
84894231823
-
Landscape of genomic alterations in cervical carcinomas
-
Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, et al. Landscape of genomic alterations in cervical carcinomas. Nature. 2014;506:371-5. doi: 10.1038/nature12881 .
-
(2014)
Nature
, vol.506
, pp. 371-375
-
-
Ojesina, A.I.1
Lichtenstein, L.2
Freeman, S.S.3
Pedamallu, C.S.4
Imaz-Rosshandler, I.5
Pugh, T.J.6
-
25
-
-
84901680089
-
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
-
Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014. doi: 10.1038/ng.2983 .
-
(2014)
Nat Genet
-
-
Wang, K.1
Yuen, S.T.2
Xu, J.3
Lee, S.P.4
Yan, H.H.5
Shi, S.T.6
-
26
-
-
84902330913
-
Mutational context and diverse clonal development in early and late bladder cancer
-
Nordentoft I, Lamy P, Birkenkamp-Demtroder K, Shumansky K, Vang S, Hornshoj H, et al. Mutational context and diverse clonal development in early and late bladder cancer. Cell Rep. 2014;7:1649-63. doi: 10.1016/j.celrep.2014.04.038 .
-
(2014)
Cell Rep
, vol.7
, pp. 1649-1663
-
-
Nordentoft, I.1
Lamy, P.2
Birkenkamp-Demtroder, K.3
Shumansky, K.4
Vang, S.5
Hornshoj, H.6
-
27
-
-
34447650761
-
High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization
-
Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, Clemmer V, et al. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res. 2005;7:R1186-98.
-
(2005)
Breast Cancer Res
, vol.7
, pp. R1186-R1198
-
-
Naylor, T.L.1
Greshock, J.2
Wang, Y.3
Colligon, T.4
Yu, Q.C.5
Clemmer, V.6
-
28
-
-
33845209913
-
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
-
Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006;10:515-27. doi: 10.1016/j.ccr.2006.10.008 .
-
(2006)
Cancer Cell
, vol.10
, pp. 515-527
-
-
Neve, R.M.1
Chin, K.2
Fridlyand, J.3
Yeh, J.4
Baehner, F.L.5
Fevr, T.6
-
29
-
-
0037198659
-
ErbB2 activation of ESX gene expression
-
Neve RM, Ylstra B, Chang CH, Albertson DG, Benz CC. ErbB2 activation of ESX gene expression. Oncogene. 2002;21:3934-8. doi: 10.1038/sj.onc.1205503 .
-
(2002)
Oncogene
, vol.21
, pp. 3934-3938
-
-
Neve, R.M.1
Ylstra, B.2
Chang, C.H.3
Albertson, D.G.4
Benz, C.C.5
-
30
-
-
2442489942
-
Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene
-
Kopp JL, Wilder PJ, Desler M, Kim JH, Hou J, Nowling T, et al. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene. J Biol Chem. 2004;279:19407-20. doi: 10.1074/jbc.M314115200 .
-
(2004)
J Biol Chem
, vol.279
, pp. 19407-19420
-
-
Kopp, J.L.1
Wilder, P.J.2
Desler, M.3
Kim, J.H.4
Hou, J.5
Nowling, T.6
-
31
-
-
34247278635
-
TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice
-
Flentjar N, Chu PY, Ng AY, Johnstone CN, Heath JK, Ernst M, et al. TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. Gastroenterology. 2007;132:1410-9. doi: 10.1053/j.gastro.2007.02.054 .
-
(2007)
Gastroenterology
, vol.132
, pp. 1410-1419
-
-
Flentjar, N.1
Chu, P.Y.2
Ng, A.Y.3
Johnstone, C.N.4
Heath, J.K.5
Ernst, M.6
-
32
-
-
84926157747
-
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes
-
Leiserson MD, Vandin F, Wu HT, Dobson JR, Eldridge JV, Thomas JL, et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet. 2015;47:106-14. doi: 10.1038/ng.3168 .
-
(2015)
Nat Genet
, vol.47
, pp. 106-114
-
-
Leiserson, M.D.1
Vandin, F.2
Wu, H.T.3
Dobson, J.R.4
Eldridge, J.V.5
Thomas, J.L.6
-
33
-
-
37349016202
-
Kruppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis
-
Nandan MO, McConnell BB, Ghaleb AM, Bialkowska AB, Sheng H, Shao J, et al. Kruppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology. 2008;134:120-30. doi: 10.1053/j.gastro.2007.10.023 .
-
(2008)
Gastroenterology
, vol.134
, pp. 120-130
-
-
Nandan, M.O.1
McConnell, B.B.2
Ghaleb, A.M.3
Bialkowska, A.B.4
Sheng, H.5
Shao, J.6
-
34
-
-
1842425769
-
Intestinal tumor progression is associated with altered function of KLF5
-
Bateman NW, Tan D, Pestell RG, Black JD, Black AR. Intestinal tumor progression is associated with altered function of KLF5. J Biol Chem. 2004;279:12093-101. doi: 10.1074/jbc.M311532200 .
-
(2004)
J Biol Chem
, vol.279
, pp. 12093-12101
-
-
Bateman, N.W.1
Tan, D.2
Pestell, R.G.3
Black, J.D.4
Black, A.R.5
-
35
-
-
84891458825
-
GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct
-
Sasaki M, Matsubara T, Nitta T, Sato Y, Nakanuma Y. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct. PLoS One. 2013;8, e81706. doi: 10.1371/journal.pone.0081706 .
-
(2013)
PLoS One
, vol.8
-
-
Sasaki, M.1
Matsubara, T.2
Nitta, T.3
Sato, Y.4
Nakanuma, Y.5
-
36
-
-
84862907854
-
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways
-
Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A. 2011;108:21188-93. doi: 10.1073/pnas.1118046108 .
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 21188-21193
-
-
Wu, J.1
Jiao, Y.2
Dal Molin, M.3
Maitra, A.4
Wilde, R.F.5
Wood, L.D.6
-
37
-
-
84902545370
-
Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin
-
Alakus H, Babicky ML, Ghosh P, Yost S, Jepsen K, Dai Y, et al. Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Med. 2014;6:43. doi: 10.1186/gm559 .
-
(2014)
Genome Med
, vol.6
, pp. 43
-
-
Alakus, H.1
Babicky, M.L.2
Ghosh, P.3
Yost, S.4
Jepsen, K.5
Dai, Y.6
-
38
-
-
84875228843
-
Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms
-
Nishikawa G, Sekine S, Ogawa R, Matsubara A, Mori T, Taniguchi H, et al. Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms. Br J Cancer. 2013;108:951-8. doi: 10.1038/bjc.2013.47 .
-
(2013)
Br J Cancer
, vol.108
, pp. 951-958
-
-
Nishikawa, G.1
Sekine, S.2
Ogawa, R.3
Matsubara, A.4
Mori, T.5
Taniguchi, H.6
-
39
-
-
84874109101
-
Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum
-
Matsubara A, Sekine S, Kushima R, Ogawa R, Taniguchi H, Tsuda H, et al. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol. 2013;229:579-87. doi: 10.1002/path.4153 .
-
(2013)
J Pathol
, vol.229
, pp. 579-587
-
-
Matsubara, A.1
Sekine, S.2
Kushima, R.3
Ogawa, R.4
Taniguchi, H.5
Tsuda, H.6
-
40
-
-
84864744918
-
Frequent activating GNAS mutations in villous adenoma of the colorectum
-
Yamada M, Sekine S, Ogawa R, Taniguchi H, Kushima R, Tsuda H, et al. Frequent activating GNAS mutations in villous adenoma of the colorectum. J Pathol. 2012;228:113-8. doi: 10.1002/path.4012 .
-
(2012)
J Pathol
, vol.228
, pp. 113-118
-
-
Yamada, M.1
Sekine, S.2
Ogawa, R.3
Taniguchi, H.4
Kushima, R.5
Tsuda, H.6
-
41
-
-
84877839648
-
Oncogenic ERBB3 mutations in human cancers
-
Jaiswal BS, Kljavin NM, Stawiski EW, Chan E, Parikh C, Durinck S, et al. Oncogenic ERBB3 mutations in human cancers. Cancer Cell. 2013;23:603-17. doi: 10.1016/j.ccr.2013.04.012 .
-
(2013)
Cancer Cell
, vol.23
, pp. 603-617
-
-
Jaiswal, B.S.1
Kljavin, N.M.2
Stawiski, E.W.3
Chan, E.4
Parikh, C.5
Durinck, S.6
-
42
-
-
84905721813
-
Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway
-
Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014;46:872-6. doi: 10.1038/ng.3030 .
-
(2014)
Nat Genet
, vol.46
, pp. 872-876
-
-
Li, M.1
Zhang, Z.2
Li, X.3
Ye, J.4
Wu, X.5
Tan, Z.6
-
43
-
-
0042307325
-
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
-
Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas 3rd CF, Hynes NE. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci U S A. 2003;100:8933-8. doi: 10.1073/pnas.1537685100 .
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 8933-8938
-
-
Holbro, T.1
Beerli, R.R.2
Maurer, F.3
Koziczak, M.4
Barbas, C.F.5
Hynes, N.E.6
-
44
-
-
84857467474
-
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
-
Jones S, Li M, Parsons DW, Zhang X, Wesseling J, Kristel P, et al. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat. 2012;33:100-3. doi: 10.1002/humu.21633 .
-
(2012)
Hum Mutat
, vol.33
, pp. 100-103
-
-
Jones, S.1
Li, M.2
Parsons, D.W.3
Zhang, X.4
Wesseling, J.5
Kristel, P.6
-
45
-
-
84875490185
-
Cancer genome landscapes
-
Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz Jr LA, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546-58. doi: 10.1126/science.1235122 .
-
(2013)
Science
, vol.339
, pp. 1546-1558
-
-
Vogelstein, B.1
Papadopoulos, N.2
Velculescu, V.E.3
Zhou, S.4
Diaz, L.A.5
Kinzler, K.W.6
-
46
-
-
84887992179
-
Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome
-
Davoli T, Xu AW, Mengwasser KE, Sack LM, Yoon JC, Park PJ, et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell. 2013;155:948-62. doi: 10.1016/j.cell.2013.10.011 .
-
(2013)
Cell
, vol.155
, pp. 948-962
-
-
Davoli, T.1
Xu, A.W.2
Mengwasser, K.E.3
Sack, L.M.4
Yoon, J.C.5
Park, P.J.6
-
47
-
-
84885129618
-
Comprehensive identification of mutational cancer driver genes across 12 tumor types
-
Tamborero D, Gonzalez-Perez A, Perez-Llamas C, Deu-Pons J, Kandoth C, Reimand J, et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep. 2013;3:2650. doi: 10.1038/srep02650 .
-
(2013)
Sci Rep
, vol.3
, pp. 2650
-
-
Tamborero, D.1
Gonzalez-Perez, A.2
Perez-Llamas, C.3
Deu-Pons, J.4
Kandoth, C.5
Reimand, J.6
-
48
-
-
84899748605
-
A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events
-
Brooks AN, Choi PS, de Waal L, Sharifnia T, Imielinski M, Saksena G, et al. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PLoS One. 2014;9, e87361. doi: 10.1371/journal.pone.0087361 .
-
(2014)
PLoS One
, vol.9
-
-
Brooks, A.N.1
Choi, P.S.2
Waal, L.3
Sharifnia, T.4
Imielinski, M.5
Saksena, G.6
-
49
-
-
85027944761
-
Dclk1 distinguishes between tumor and normal stem cells in the intestine
-
Nakanishi Y, Seno H, Fukuoka A, Ueo T, Yamaga Y, Maruno T, et al. Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet. 2013;45:98-103. doi: 10.1038/ng.2481 .
-
(2013)
Nat Genet
, vol.45
, pp. 98-103
-
-
Nakanishi, Y.1
Seno, H.2
Fukuoka, A.3
Ueo, T.4
Yamaga, Y.5
Maruno, T.6
-
50
-
-
84919769544
-
Mutational landscape of aggressive cutaneous squamous cell carcinoma
-
Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014;20:6582-92. doi: 10.1158/1078-0432.CCR-14-1768 .
-
(2014)
Clin Cancer Res
, vol.20
, pp. 6582-6592
-
-
Pickering, C.R.1
Zhou, J.H.2
Lee, J.J.3
Drummond, J.A.4
Peng, S.A.5
Saade, R.E.6
|